Relationship between nigro-striatal dopaminergic dysfunction and affective symptoms in de novo Parkinson's disease

被引：0
|
作者：
Frosini, D. [1 ]
Kiferle, L. [1 ]
Del Prete, E. [1 ]
Vanelli, F. [1 ]
Volterrani, D. [1 ]
Bonuccelli, U. [1 ]
Ceravolo, R. [1 ]
机构：
[1] Univ Pisa, Pisa, Italy
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S90 / S91
页数：2
相关论文
共 50 条
  • [31] Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes
    Boccalini, Cecilia
    Carli, Giulia
    Pilotto, Andrea
    Padovani, Alessandro
    Perani, Daniela
    NEUROBIOLOGY OF DISEASE, 2022, 167
  • [32] Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease
    Ye, Byoung Seok
    Jeon, Seun
    Yoon, Sohoon
    Kang, Seong Woo
    Baik, KyoungWon
    Lee, Yoonju
    Chung, Su Jin
    Oh, Jungsu S.
    Moon, Hyojeong
    Kim, Jae Seung
    Lee, Phil Hyu
    Sohn, Young Ho
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (02): : 197 - 204
  • [33] Neuronal degeneration and loss in nigro-striatal system in Alzheimer disease, Down syndrome, and Parkinson disease.
    Badmaev, E
    Wegiel, J
    Nowicki, K
    Kuchna, I
    Tarnawski, M
    Wrzolek, M
    Pirttila, T
    Kivimaki, T
    Lehtimaki, T
    Reisberg, B
    de Leon, M
    Wisniewski, T
    Silverman, W
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 545 - 545
  • [34] Relationship between nigrostriatal dopaminergic degeneration and urinary symptoms in Parkinson's disease
    Winge, K
    Friberg, L
    Werdelin, L
    Nielsen, KK
    Stimpel, H
    MOVEMENT DISORDERS, 2004, 19 : S210 - S210
  • [35] ROLE OF THE RET/GDNF SIGNALING PATHWAY IN PROTECTION OF THE NIGRO-STRIATAL SYSTEM IN A MPTP MOUSE MODEL FOR PARKINSON'S DISEASE
    Drinkut, A.
    Kramer, E. R.
    Schulz, J. B.
    Kuegler, S.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 256 - 256
  • [36] Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment
    Kim, Han-Joon
    Park, So-Young
    Cho, Yong-Jin
    Hong, Keun-Sik
    Cho, Joong-Yang
    Seo, So-Young
    Lee, Dong-Ha
    Jeon, Beom S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 287 (1-2) : 200 - 204
  • [37] Role of the RET/GDNF signaling pathway in protection of the nigro-striatal system in a MPTP mouse model for Parkinson's disease
    Drinkut, A.
    Nagel, F.
    Kramer, E. R.
    Kuegler, S.
    Schulz, J. B.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 49 - 50
  • [38] Cortical excitability changes induced by L-dopa mirror the unbalanced nigro-striatal denervation in Parkinson's disease
    Isaias, I. U.
    Turco, F.
    Rosanova, M.
    Marotta, G.
    Frazzitta, G.
    Landi, C.
    Perretti, A.
    del Giardino, L. Giusti
    Canesi, M.
    Massimini, M.
    Pezzoli, G.
    Casarotto, S.
    MOVEMENT DISORDERS, 2015, 30 : S10 - S11
  • [39] Non-motor symptoms in de novo Parkinson's disease before and after dopaminergic treatment
    Kim, H. -J.
    Park, S. -Y.
    Cho, Y. -J.
    Hong, K. -S.
    Cho, J. -Y.
    Seo, S. -Y.
    Lee, D. -H.
    Jeon, B. S.
    MOVEMENT DISORDERS, 2009, 24 : S383 - S383
  • [40] Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson's Disease
    Umehara, Tadashi
    Oka, Hisayoshi
    Nakahara, Atsuo
    Shiraishi, Tomotaka
    Sato, Takeo
    Matsuno, Hiromasa
    Komatsu, Teppei
    Omoto, Shusaku
    Murakami, Hidetomo
    Iguchi, Yasuyuki
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (02) : 665 - 673
12345